ArticleGynecologic oncology2020

Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.

Enes Taylan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.